Funding for this research was provided by:
National Heart, Lung, and Blood Institute (K23 HL 150280)
National Institutes of Health (UL1 TR001873)
Parker B Francis Foundation
Article History
Accepted: 19 November 2020
First Online: 14 December 2020
Declarations
:
: This study was supported in part by the National Institutes of Health (Grant numbers UL1 TR001873 to MRB and K23 HL 150280 to MRA) and the Parker B Francis Foundation. None of the listed funding sources were involved in the design or conduct of this study; the collection, management, analysis or interpretation of data; the preparation, review, or approval of this manuscript; or the decision to submit this manuscript for publication.
: Dr. Anderson has no conflicts of interest that are directly relevant to the content of this article. Dr. Baldwin served as site co-investigator for Gilead Sciences Remdesivir trials GS-US-540-5774 and GS-US-540-5773 and received no funding. Dr. Bach has received personal fees and non-financial support from the American Society for Health-System Pharmacists, United Rheumatology, Oppenheimer & Co, Kaiser Permanente Institute for Health Policy, the Congressional Budget Office, America’s Health Insurance Plans, and Geisinger; personal fees from WebMD, Defined Health, JMP Securities, Mercer, Foundation Medicine, Grail, Morgan Stanley, NYS Rheumatology Society, Cello Health, Anthem, Magellan Health, EQRx, Meyer Cancer Center of Weill Cornell Medicine, and the National Pharmaceutical Council; personal fees, non-financial support, and other support from Oncology Analytics; and grants from Kaiser Permanente and Arnold Ventures. All listed support was outside the submitted work.
: Data sharing would be considered with appropriate institutional review board approval.
: Columbia University IRB#AAAS9982.
: Not applicable.
: Code is available upon reasonable request.
: MRA and MRB had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Study concept and design, drafting of the manuscript, and critical revision of the manuscript for important intellectual content: MRA, PBB, MRB. Acquisition, analysis, and interpretation of data and statistical analysis: MRA, MRB.